Home・Stock List・Agilent Technologies Inc

Agilent Technologies Inc

Closed

SectorHealthcare

139.31 -0.27

Buy Sell

Overview

Share price change

24h

Current

Min

138.06

Max

140.31

Key metrics
By Trading Economics
Income	34M 339M
Sales	37M 1.8B
P/E Sector Avg	27.745 64.641
EPS	1.49
Dividend yield	0.73
Profit margin	18.474
Employees	18,000
EBITDA	44M 500M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+12.11% upside

Dividends
By Acuity
Dividend yield Sector Avg	0.73% 2.31%
Next Earnings	26 Aug 2026
Next Dividend date	21 Oct 2026
Next Ex Dividend date	29 Sept 2026

Market Stats
By TradingEconomics
Market Cap	6.5B 39B
Previous open	139.58
Previous close	139.31

News Sentiment

By Acuity

16%

84%

22 / 340 Healthcare

Agilent Technologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 Jul 2026, 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30 Jul 2026, 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29 Jul 2026, 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28 Jul 2026, 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27 Jul 2026, 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24 Jul 2026, 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23 Jul 2026, 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22 Jul 2026, 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21 Jul 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20 Jul 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Peer Comparison

Price change

Agilent Technologies Inc Forecast

Price Target

By TipRanks

12.11% upside

12 Months Forecast

Average 155.13 USD 12.11%

High 180 USD

Low 135 USD

Based on 16 Wall Street analysts offering 12 month price targets forAgilent Technologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

Buy

Hold

Sell

Based on 16 analysts giving stock ratings to Agilent Technologies Inc - Dist in the past 3 months.

Sentiment

By Acuity

22 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.